Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release--a feasibility study using bisphosphonates.
The prolonged delivery of hydrophilic drug salts from hydrophobic polymer carriers at high drug loading is an ambitious goal. Pamidronate disodium salt (APD) containing implants prepared from spray-dried microparticles were investigated using a laboratory ram extruder. An APD-containing polymer matrix consisting of an APD-chitosan implant embedded in the biodegradable polymer D,L-poly(lactide-co-glycolide acid-glucose) (PLG-GLU) was compared with a matrix system with the micronized drug distributed in the PLG-GLU. The APD-chitosan matrix system showed a triphasic release behaviour at loading levels of 6.86 and 15.54% (w/w) over 36 days under in-vitro conditions. At higher loading (31.92%), a drug burst was observed within 6 days due to the formation of pores and channels in the polymeric matrix. In contrast, implants containing the micronized drug showed a more continuous release profile over 48 days up to a loading of 31.78% (w/w). At a drug loading of 46.17% (w/w), a drug burst was observed. Using micronized drug salts and reducing the surface area available for diffusion, parenteral delivery systems for highly water-soluble drug candidates were shown to be technically feasible at high drug loadings.
Weidenauer
U
U
Department of Pharmaceutics and Biopharmacy, Philipps-University, D-35032 Marburg, Germany.
Bodmer
D
D
Kissel
T
T
D000277:Adjuvants, Pharmaceutic; D000893:Anti-Inflammatory Agents; D001672:Biocompatible Materials; D001673:Biodegradation, Environmental; D002686:Chitin / Q000031:analogs & derivatives*; D048271:Chitosan; D004164:Diphosphonates; D004339:Drug Compounding / Q000379:methods*; D004343:Drug Implants; D005240:Feasibility Studies; D019344:Lactic Acid; D008855:Microscopy, Electron, Scanning; D008863:Microspheres; D000077268:Pamidronate; D011091:Polyesters; D011100:Polyglycolic Acid; D013395:Sucrose; D013499:Surface Properties
D000277:Adjuvants, Pharmaceutic; D000893:Anti-Inflammatory Agents; D001672:Biocompatible Materials; D004164:Diphosphonates; D004343:Drug Implants; D011091:Polyesters; C489708:polymer D,L-poly(lactide-co-glycolide acid-glucose); D002686:Chitin; D011100:Polyglycolic Acid; D019344:Lactic Acid; D013395:Sucrose; D048271:Chitosan; D000077268:Pamidronate